No Data
No Data
Pfizer Gains FDA Approval for Colorectal-Cancer Treatment
Wall Street Suffers Worst Week in Over a Month After Fed Delivers a Reality Check
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Novo Nordisk Raises Expectations for Eli Lilly After CagriSema Slipup
Did Novo-Nordisk A/S fall, leaving Eli Lilly and Co to dominate the weight loss medication market?
Novo-Nordisk A/S faced a "Waterloo," with new drug effects falling short of expectations, causing a dramatic drop in stock prices. The landscape of the weight loss drug market is quietly changing; will Eli Lilly and Co become a sole oligopoly?
The Health Care Select Sector SPDR Fund To Go Ex-Dividend On December 23rd, 2024 With 0.62165 USD Dividend Per Share